The MMRF fights for a world where every person has precisely what they need to prevent or defeat multiple myeloma whenever they need it.

Conditions Covered:Multiple Myeloma, Cancer

Latest by Multiple Myeloma Research Foundation

Treatment FAQs

Over the years, the Multiple Myeloma Research Foundation (MMRF) has collected questions from patients like you, who are just starting treatment. Here you will find answers to the most frequently asked questions.

Multiple Myeloma Life Expectancy

The life expectancy of multiple myeloma patients typically varies on several factors.

Classifying Multiple Myeloma

Multiple myeloma is classified into one of three categories. Classification of multiple myeloma is important because immediate disease-directed treatment is needed only for symptomatic myeloma.

Managing Treatment Related Side Effects

Myeloma medications, like all medications, have the potential to cause side effects.

Multiple Myeloma Tests

Diagnostic testing for multiple myeloma is important, because many myeloma patients don’t have any multiple myeloma symptoms until their disease has reached more advanced stages.

Multiple Myeloma Complications

The complications of multiple myeloma stem from myeloma’s effect on the body as well as its symptoms. As the myeloma cells grow in excess, they disrupt normal cell production, which can result in numerous health complications.

Choosing A Doctor

Choosing a doctor that specializes in multiple myeloma is one of the most important decisions you will have to make.

Multiple Myeloma Genetic Factors

Multiple myeloma genetic factors are abnormalities in the number or structure of chromosomes. Research has shown that genetic factors may be linked to multiple myeloma.

Multiple Myeloma Causes

The cause of multiple myeloma has not yet been identified. Although scientists have made advancements in understanding how multiple myeloma develops, it is unclear as to what exactly causes the disease.

Multiple Myeloma Symptoms

Multiple myeloma symptoms may vary by patient, with the early stages of myeloma often presenting no visible symptoms or signs.